Skip to content
2-Day Shipping*
Secure Online Rx
Personalized Treatments
8,750+ Patients
Discreet Shipping
Compounded in the USA
No Surprises, Upfront Pricing
24/7 Provider Messaging
Customized to Your Needs
Same-Day Doctor Visits & Rx
FSA & HSA Eligible
100% Entirely Online
klarnaPay with Klarna
Guide

Traveling with tirzepatide

What the Zepbound® label allows at room temperature, what the TSA says about medication at screening, and how to plan doses across a trip.

Three questions a trip raises

A weekly injectable medication that needs refrigeration raises three questions the moment a trip is planned: how long it can be out of the refrigerator, how it gets through airport security, and what happens to the weekly schedule when the days and the time zones move. This guide answers each from the sources this site uses: the FDA-approved Zepbound® label for what the molecule tolerates, the Transportation Security Administration’s own pages for the airport, and the pharmacy label and your care team for the compounded vial in your bag.

This is general information and not medical advice. The Zepbound® label describes the branded product in its own packaging. Personalized Compounded tirzepatide, which Bodi Envi’s programs may include, is not FDA-approved and is not equivalent to Zepbound®, and its storage rules come from the pharmacy that prepared it. Ask your care team before the trip, not from the departure gate.

Personalized compounded medications differ from commercially available brand-name products in formulation, concentration, excipients, preparation methods, and other characteristics. Accordingly, clinical data from studies involving brand-name products should not be assumed to apply to personalized compounded formulations.

At this time, the studies referenced above have not evaluated the specific personalized compounded formulations being provided. Therefore, no claims of equivalence in safety, efficacy, quality, or clinical outcomes should be inferred from these studies.

What the Zepbound® label allows

The Zepbound® prescribing information sets refrigeration between 36°F and 46°F as the normal state, says never to freeze the medication or use it if it has been frozen, and says to protect it from heat and light in its original carton. It then gives specific room temperature allowances for the branded presentations. A single-dose pen or single-dose vial may, if needed, be stored unrefrigerated at temperatures not exceeding 86°F for up to a total of 21 days, and must be discarded after a total of 21 days at room temperature. An unopened multi-dose vial or multi-dose pen stored at room temperature up to 86°F must be thrown away after 30 days. Once a multi-dose vial or pen has been opened, it may be kept in the refrigerator or at room temperature up to 86°F, and must be thrown away after 30 days at room temperature, 30 days after first use, or after four weekly doses, whichever comes first.

Two things to notice. The allowances are totals: days at room temperature add up across the life of the product, so a pen that spent a week out before a trip has a week less available during it. And 86°F is the ceiling, which a car in summer, a beach bag or a hotel windowsill can exceed quickly. The label’s rule is to protect the medication from heat, and the allowance is for room temperature, not for heat.

Those rules describe Zepbound® in its manufacturer’s packaging. They are the closest published statement of what tirzepatide tolerates, and a compounded vial should not be assumed to match them.

Personalized compounded medications differ from commercially available brand-name products in formulation, concentration, excipients, preparation methods, and other characteristics. Accordingly, clinical data from studies involving brand-name products should not be assumed to apply to personalized compounded formulations.

At this time, the studies referenced above have not evaluated the specific personalized compounded formulations being provided. Therefore, no claims of equivalence in safety, efficacy, quality, or clinical outcomes should be inferred from these studies.

The pharmacy label governs a compounded vial

Personalized Compounded tirzepatide arrives with a label from the pharmacy that prepared it, and that label’s storage instructions are the ones that apply to your vial: how cold to keep it, whether it may be out of the refrigerator and for how long, and how long it lasts once opened. Before a trip, read it, and if it does not answer the travel question, contact the pharmacy using the details on the label, or message your care team through the patient portal.

The FDA’s statement on unapproved GLP-1 drugs adds two rules that apply on the road as at home. Do not use any injectable GLP-1 drug that has become warm; the statement says this can affect the drug’s quality. And discard a multi-dose vial 28 days after first use even if medication remains, and use a new sterile needle and syringe for every dose. A trip does not extend either.

The practical arrangement that follows is to carry the vial in an insulated bag with cold packs, keep it out of direct sun and hot vehicles, put it in a refrigerator on arrival, and check its appearance before each dose. The Zepbound® label says to inspect the medication visually before use and to use it only if it is clear and free of particles, and that standard applies to a vial. If the vial has been outside its pharmacy label’s allowance, contact the pharmacy or your care team before using it.

Airport screening, as the TSA describes it

The Transportation Security Administration’s medication FAQ says that all passenger items must undergo security screening, and recommends that medication be clearly labelled to facilitate the process. It says passengers may bring medically necessary liquids, medications and creams in excess of 3.4 ounces or 100 milliliters in a carry-on bag, and that they must be removed from the carry-on bag to be screened separately from the rest of your belongings. The TSA’s what can I bring page for liquid medications says the agency allows larger amounts of medically necessary liquids, gels and aerosols in reasonable quantities for your trip, that they must be declared to security officers at the checkpoint for inspection, and that the final decision rests with the TSA officer on whether an item is allowed through.

Applied to a compounded vial, that means: carry it in your cabin bag rather than checked luggage, in the pharmacy packaging with the pharmacy label visible, take it out at the checkpoint and tell the officer what it is, and expect it to be screened separately. The cold packs that keep it cool are part of the medically necessary kit; declare them with it. Keep needles and syringes with the medication and labelled. The TSA pages this guide cites do not address every situation, and they say the officer decides; for anything they do not cover, ask the TSA directly before you fly.

There is a temperature reason to prefer the cabin bag as well. The labels say to protect the medication from heat and freezing, and neither an aircraft hold nor a checked bag waiting on a tarmac is under your control. A cabin bag with a cold pack is.

Time zones, travel days and the weekly schedule

A weekly injection meets a trip in two ways: the dose day may fall on a travel day, and a long east or west move shifts the clock. The Zepbound® label describes, for the branded product, how the schedule bends. If a dose is missed, it may be taken as soon as possible within four days, or 96 hours, of the scheduled time; if more than four days have passed, the missed dose is skipped and the next taken on the regular day. The day of weekly administration can be changed, if necessary, as long as the time between two doses is at least three days, or 72 hours. A time zone shift of a few hours is well inside those margins.

Those are the label’s descriptions for Zepbound®. With a compounded prescription, your provider’s plan governs, and the right time to ask how to handle a travel day or a change of dose day is before the trip, through the patient portal. Do not adjust the dose to compensate for a shifted day; the FDA has reported adverse events in patients given compounded doses beyond what the label describes.

A short pre-trip checklist

Read the pharmacy label for the room temperature allowance and the in-use period, and ask the pharmacy or care team if it is silent. Confirm you have enough medication, needles and syringes for the trip plus a margin. Pack the medication in an insulated bag with cold packs, in its labelled pharmacy packaging, in your cabin bag. Plan to declare it at the checkpoint and have it screened separately. Note your dose day against your itinerary, and ask your care team in advance about any shift. On arrival, refrigerate it. Before each dose, check its appearance and the 28 day count. And if anything has gone wrong with temperature, contact the pharmacy or your care team before injecting.

Bodi Envi’s programs include messaging with your care team through the patient portal, and a licensed provider, through Wasef Health, PC for applicable programs, makes every clinical decision including how a schedule should bend. Bodi Envi is a LegitScript-certified U.S. telehealth platform and not a medical practice, pharmacy or medication manufacturer; its shipping policy states that it does not ship outside the United States. Personalized Compounded tirzepatide is not FDA-approved and is not equivalent to Zepbound®. This guide is general information and not medical advice, and your pharmacy and provider are the people to ask.

Questions

Frequently asked questions

Short answers to the questions people ask most about this topic.

For the branded product, the Zepbound® label says a single-dose pen or vial may be kept unrefrigerated at up to 86°F for a total of 21 days and then discarded, and an unopened multi-dose pen or vial for 30 days. A compounded vial is a different product, and the pharmacy label gives the allowance that applies to it.

The TSA's medication guidance says medically necessary liquids in excess of 3.4 ounces are allowed in carry-on bags, that they must be removed from the bag and declared to officers for separate screening, that medication should be clearly labelled, and that the final decision rests with the TSA officer at the checkpoint.

The TSA's pages address carry-on screening of medication and do not require checking it. The labels say to protect the medication from heat and freezing, and the hold of an aircraft and a checked bag on a tarmac are not temperature controlled in the way a cabin bag you carry is. Keep it with you, in a cooler bag, following the pharmacy label.

The Zepbound® label says a missed dose may be taken within four days of the scheduled time and is otherwise skipped, and that the weekly injection day can be changed as long as at least three days pass between doses. Those describe the branded product; with a compounded prescription, ask your care team before the trip how to handle a shift.

The FDA advises against using any injectable GLP-1 drug that has arrived warm, and the labels say to protect the medication from heat. If a vial has been outside the allowance on its pharmacy label, contact the pharmacy or your care team before using it rather than guessing.

The TSA's medication FAQ says all passenger items undergo screening and recommends that medication be clearly labelled. Carry the medication in its pharmacy packaging with the label, and keep needles with it. Ask the TSA directly for anything the pages do not cover.

Sources

  1. Zepbound® (tirzepatide) injection prescribing information, DailyMed, revised August 2026, checked September 2026.
  2. Transportation Security Administration, I am traveling with medication, are there any requirements I should be aware of?, checked September 2026.
  3. Transportation Security Administration, What Can I Bring, Medications (Liquid), checked September 2026.
  4. FDA, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, dated September 1, 2026, checked September 2026.

Related

Important information about compounded medications

Personalized compounded semaglutide and personalized compounded tirzepatide are not FDA-approved and are not equivalent to FDA-approved products.

The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.

Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.

Treatment is not guaranteed. A licensed healthcare provider determines whether treatment is appropriate for each individual patient. Individual experiences and outcomes vary. If a patient is not qualified, a refund will be issued.

Bodi Envi is not a medical practice, pharmacy, or medication manufacturer. Brand names are trademarks of their respective owners.

Ready when you are

Start with an online assessment.

Answer a few questions about your health and goals. A licensed provider reviews your answers and decides whether treatment is appropriate for you.